The Vaccines Manufacturing and Innovation Centre in Oxfordshire (VMIC), UK has selected Lonza’s MODA-EM Solution to digitize its Microbiology Quality Control operations.

The MODA EM Platform will form a vital part of ongoing work that will support the accelerated timelines of VMIC coming online – a year ahead of schedule.

VMIC is a not-for-profit organization established to provide the UK’s first strategic vaccine development and advanced manufacturing capability. The MODA-EM Solution is a comprehensive informatics platform that automates QC processes for regulated manufacturing in the Life Sciences industry.

The ongoing COVID-19 pandemic has accelerated multiple industry trends, including digitalization and automation. Implementing paperless solutions can help researchers meet aggressive timelines and fit into Industry 4.0 initiatives. Lonza’s next-generation solution for pharmaceutical QC will allow paperless management of a wealth of microbiological data. The electronic approach reinforces data integrity compliance, enables real-time access to data, and provides fast input necessary to make informed decisions.

The automation of the QC laboratory has seen slow adoption by organizations due to cost constraints and flexibility concerns. The MODA-EM™ Data Acquisition Platform for automated and paperless QC processes aims to ease implementation to achieve regulatory compliance and maximize employee utilization.

Dr. Orla Cloak, Global Director of Testing Solutions and Informatics, Lonza, said, “We’re proud that VMIC has made the decision to adopt Lonza’s MODA-EM™ Quality Control Microbiology Platform. This project comes at a critical time when vaccine developers and manufacturers are scaling up to meet vital global health needs. We look forward to working with VMIC to enable vaccine producers with best practices and the highest levels of data integrity in paperless manufacturing and quality as they serve an important role in the future of public health.”